Top Markets
#1 Bitway Bitway +55.02%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.19%
#3 Starpower Starpower +37.49%
#4 Pons Pons +34.50%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.80%
#6 aelf aelf +22.66%
#7 SkyAI SkyAI +19.87%
#8 Ocean Protocol Ocean Protocol +18.26%
#9 OpenEden OpenEden +18.13%
#10 Mubarak Mubarak +15.20%
Coin of the day
Bitway Bitway
Settings
Language
ENGLISH
Currency
USD
Theme
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Rank in Stocks #29370
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Share Price
$3.86
Market Cap
$21.49M
Change (1 day)
-0.17%
Change (1 year)
-25.27%
Country
JP
Trade Human Metabolome Technologies, Inc. (6090)

Category

Healthcare
Stock price history for Human Metabolome Technologies, Inc. (6090)
Highest end of day price: $3.90 on 2026-08-01

Lowest end of day price: $38.92 on 2013-12-01
Stock price history of Human Metabolome Technologies, Inc. from 2013 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 6.42%
2025 5.53%
2024 -8.60%
2023 -16.34%
2022 -3.84%
2021 -27.40%
2020 -0.20%
2019 -31.00%
2018 -39.33%
2017 33.64%
2016 94.29%
2015 -35.63%
2014 -72.82%
2013 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.55 39.36%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.18%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.89 451.38%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $754.06 8.70%
CH